Cleared Traditional

K100927 - SURGIAID (FDA 510(k) Clearance)

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2011
Decision
303d
Days
-
Risk

K100927 is an FDA 510(k) clearance for the SURGIAID. Classified as Wound Dressing With Animal-derived Material(s) (product code KGN).

Submitted by Maxigen Biotech, Inc. (Flagstaff, US). The FDA issued a Cleared decision on February 2, 2011 after a review of 303 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Maxigen Biotech, Inc. devices

Submission Details

510(k) Number K100927 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 05, 2010
Decision Date February 02, 2011
Days to Decision 303 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
189d slower than avg
Panel avg: 114d · This submission: 303d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KGN Wound Dressing With Animal-derived Material(s)
Device Class -

Regulatory Peers - KGN Wound Dressing With Animal-derived Material(s)

All 182
Devices cleared under the same product code (KGN) and FDA review panel - the closest regulatory comparables to K100927.
Derma-Gide
K260532 · Geistlich Pharma AG · Mar 2026
LacertaMatrix
K260218 · Lacerta Life Sciences · Feb 2026
CollOvine™ Wound Powder
K253140 · Ovigenex, LLC · Feb 2026
Device 104 Particulate
K251323 · Geistlich Pharma AG · Jan 2026
LacertaMatrix
K252673 · Lacerta Life Science · Dec 2025
Theracor
K253339 · Stimlabs, LLC · Dec 2025